BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11587205)

  • 1. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
    Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
    Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
    MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
    Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
    van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
    Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
    Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
    Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).
    Hansen-Hagge TE; Schäfer M; Kiyoi H; Morris SW; Whitlock JA; Koch P; Bohlmann I; Mahotka C; Bartram CR; Janssen JW
    Leukemia; 2002 Nov; 16(11):2205-12. PubMed ID: 12399963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
    Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
    Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of Hox11L2 expression in children with T-ALL.
    Mauvieux L; Leymarie V; Helias C; Perrusson N; Falkenrodt A; Lioure B; Lutz P; Lessard M
    Leukemia; 2002 Dec; 16(12):2417-22. PubMed ID: 12454747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
    Cavé H; Suciu S; Preudhomme C; Poppe B; Robert A; Uyttebroeck A; Malet M; Boutard P; Benoit Y; Mauvieux L; Lutz P; Méchinaud F; Grardel N; Mazingue F; Dupont M; Margueritte G; Pages MP; Bertrand Y; Plouvier E; Brunie G; Bastard C; Plantaz D; Vande Velde I; Hagemeijer A; Speleman F; Lessard M; Otten J; Vilmer E; Dastugue N;
    Blood; 2004 Jan; 103(2):442-50. PubMed ID: 14504110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia.
    Su XY; Busson M; Della Valle V; Ballerini P; Dastugue N; Talmant P; Ferrando AA; Baudry-Bluteau D; Romana S; Berger R; Bernard OA
    Genes Chromosomes Cancer; 2004 Nov; 41(3):243-9. PubMed ID: 15334547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
    Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
    Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype.
    Salvati PD; Ranford PR; Ford J; Kees UR
    Oncogene; 1995 Oct; 11(7):1333-8. PubMed ID: 7478554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).
    Nagel S; Kaufmann M; Drexler HG; MacLeod RA
    Cancer Res; 2003 Sep; 63(17):5329-34. PubMed ID: 14500364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality.
    Hélias C; Leymarie V; Entz-Werle N; Falkenrodt A; Eyer D; Costa JA; Cherif D; Lutz P; Lessard M
    Leukemia; 2002 Jan; 16(1):7-12. PubMed ID: 11840257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24.
    Kennedy MA; Gonzalez-Sarmiento R; Kees UR; Lampert F; Dear N; Boehm T; Rabbitts TH
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8900-4. PubMed ID: 1681546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
    Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
    Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
    Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
    Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of translocations involving the HOX11/TCL3-locus in 10q24 by interphase fluorescence in situ hybridization.
    Kahl C; Gesk S; Harder L; Harbott J; French L; Deloukas P; Grote W; Schlegelberger B; Siebert R
    Cancer Genet Cytogenet; 2001 Aug; 129(1):80-4. PubMed ID: 11520572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
    Ballerini P; Busson M; Fasola S; van den Akker J; Lapillonne H; Romana SP; Marynen P; Bernard OA; Landman-Parker J; Berger R
    Leukemia; 2005 Mar; 19(3):468-70. PubMed ID: 15674415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.